CVE-2025-61940
Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication
- Published
- Last modified
- Where the record stands: published, rejected by its publisher, or superseded by another id.What do these mean? →
- published
- Whether CISA lists it in its Known Exploited Vulnerabilities catalog: proof that attackers are using it.What do these mean? →
- Not listed in CISA KEV
- Fix
- Fixed in 23.0
- Whether working attack code is public (Exploit-DB, Metasploit, Nuclei or GitHub). Public code makes attacks easier.What do these mean? →
- None on Exploit-DB, Metasploit or GitHub
CISA's decision points: whether it is exploited, whether attacks can be automated, and how much control an attacker gets. Assessed (SSVC 2.0.3).What do these mean? →
- Exploitation: none
- Automatable: no
- Technical impact: total
Summary
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
Timeline
- CVE published
- CISA SSVC assessment
Exploitation: none · Automatable: no · Technical impact: total
- Record last updated
Affected versions
- Mirion Medical EC2 Software NMIS BioDose
fixed in 23.0